HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Xiang Selected Research

Rhinosinusitis

12/2023The efficacy of steroid-eluting stents on the local inflammation of chronic rhinosinusitis with nasal polyposis after endoscopic sinus surgery: a multicenter prospective longitudinal study.
12/2023Predictive Value of Eosinophil Cationic Protein in Nasal Secretions in Eosinophilic Chronic Rhinosinusitis.
11/2023[The efficacy and safety of glucocorticoid stent implantation compared with oral glucocorticoid during perioperative period in chronic rhinosinusitis with nasal polyps].
8/2023Diagnostic value of myeloperoxidase and eosinophil cationic protein in nasal secretions for endotypes of chronic rhinosinusitis.
3/2022The comparation of different oral corticosteroids withdrawal methods for nasal polyp surgery.
1/2022The hMeDIP-Seq identified INPP4A as a novel biomarker for eosinophilic chronic rhinosinusitis with nasal polyps.
1/2020Predictive and Diagnostic Value of Nasal Nitric Oxide in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Xiang Research Topics

Disease

148Neoplasms (Cancer)
03/2024 - 06/2002
63Breast Neoplasms (Breast Cancer)
07/2022 - 07/2003
40Neoplasm Metastasis (Metastasis)
10/2021 - 12/2002
18Inflammation (Inflammations)
12/2023 - 04/2011
12Carcinoma (Carcinomatosis)
11/2019 - 12/2002
11Carcinogenesis
11/2021 - 11/2004
10Infections
11/2023 - 02/2010
9Lung Neoplasms (Lung Cancer)
03/2024 - 04/2005
9Hepatocellular Carcinoma (Hepatoma)
01/2019 - 05/2009
8Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 08/2012
7Rhinosinusitis
12/2023 - 01/2020
7Allergic Rhinitis
12/2023 - 08/2015
7Melanoma (Melanoma, Malignant)
01/2016 - 12/2002
6Neurodegenerative Diseases (Neurodegenerative Disease)
02/2024 - 01/2017
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 06/2004
6Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 09/2015
4Mitochondrial Diseases (Mitochondrial Disease)
02/2024 - 01/2017
4Fibrosis (Cirrhosis)
02/2024 - 08/2014
4Nasal Polyps (Nasal Polyp)
11/2023 - 01/2020
4Colonic Neoplasms (Colon Cancer)
07/2023 - 05/2003
4Triple Negative Breast Neoplasms
01/2020 - 05/2015
4Atherosclerosis
09/2015 - 05/2014
3Cardiomyopathies (Cardiomyopathy)
01/2024 - 01/2017
3Hypersensitivity (Allergy)
11/2023 - 01/2019
3COVID-19
01/2023 - 11/2021
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 02/2015
3Polydactyly (Polydactylism)
01/2022 - 01/2016
3Adenocarcinoma of Lung
03/2021 - 01/2016
3Hypertriglyceridemia
01/2020 - 04/2015
3Diarrhea
01/2020 - 10/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 08/2012
3Prostatic Neoplasms (Prostate Cancer)
05/2017 - 08/2011
3Necrosis
01/2016 - 06/2009

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2004
19VaccinesIBA
11/2021 - 12/2002
16Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2012
14CateninsIBA
07/2022 - 01/2013
14asparaginylendopeptidase (legumain)IBA
01/2022 - 01/2006
14DNA VaccinesIBA
01/2013 - 12/2002
11LipidsIBA
02/2024 - 11/2009
11Transcription Factors (Transcription Factor)IBA
01/2020 - 07/2003
10RNA (Ribonucleic Acid)IBA
04/2023 - 01/2014
10Small Interfering RNA (siRNA)IBA
10/2022 - 01/2012
9LigandsIBA
03/2021 - 06/2002
9MicroRNAs (MicroRNA)IBA
01/2021 - 11/2016
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2006
8Messenger RNA (mRNA)IBA
10/2022 - 11/2004
8Interleukin-2 (IL2)IBA
01/2022 - 05/2004
8CytokinesIBA
01/2021 - 03/2007
7DNA (Deoxyribonucleic Acid)IBA
01/2023 - 05/2003
6AntigensIBA
11/2023 - 04/2008
6Monoclonal AntibodiesIBA
01/2022 - 04/2011
6Cancer VaccinesIBA
09/2020 - 09/2011
5EnzymesIBA
03/2024 - 06/2016
5IntegrinsIBA
01/2022 - 06/2002
5CollagenIBA
01/2022 - 07/2007
5Firefly LuciferasesIBA
08/2014 - 07/2012
5AutoantigensIBA
04/2008 - 12/2002
4Fatty Acids (Saturated Fatty Acids)IBA
03/2024 - 05/2017
4Cisplatin (Platino)FDA LinkGeneric
02/2024 - 12/2018
4oxidized low density lipoproteinIBA
04/2023 - 05/2015
4NucleotidesIBA
10/2022 - 10/2019
4Peptides (Polypeptides)IBA
01/2022 - 05/2004
4Carrier Proteins (Binding Protein)IBA
01/2022 - 01/2019
4Phosphotransferases (Kinase)IBA
01/2022 - 01/2018
4Indicators and Reagents (Reagents)IBA
10/2021 - 07/2005
4Conditioned Culture MediaIBA
01/2021 - 01/2013
4p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 10/2013
4Nucleic AcidsIBA
01/2019 - 07/2007
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2019 - 05/2003
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2016 - 12/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 08/2006
4Ganciclovir (Cytovene)FDA LinkGeneric
06/2014 - 07/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
07/2012 - 01/2006
4A-Form DNA (A-DNA)IBA
04/2005 - 12/2002
3Glucose (Dextrose)FDA LinkGeneric
08/2022 - 01/2019
3Long Noncoding RNAIBA
03/2022 - 05/2017
3Tuberculin (PPD)IBA
01/2022 - 01/2016
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2019
3Neutralizing AntibodiesIBA
01/2022 - 01/2016
3Interleukin-18 (Interleukin 18)IBA
11/2021 - 07/2003
3Protein Isoforms (Isoforms)IBA
10/2021 - 06/2016
3Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2020
3LipopolysaccharidesIBA
01/2019 - 11/2015
3Zinc Finger E-box-Binding Homeobox 1IBA
01/2018 - 01/2017
3Therapeutic UsesIBA
10/2017 - 06/2014
3Calcitriol Receptors (Calcitriol Receptor)IBA
03/2017 - 10/2012
3T0901317IBA
01/2016 - 04/2014
3Liver X ReceptorsIBA
01/2016 - 04/2014
3Antineoplastic Agents (Antineoplastics)IBA
11/2015 - 06/2014
3InterferonsIBA
02/2015 - 07/2014
3Green Fluorescent ProteinsIBA
01/2013 - 07/2012
3ProteomeIBA
12/2012 - 11/2004
2Immune Checkpoint InhibitorsIBA
03/2024 - 01/2021
2Amyloid (Amyloid Fibrils)IBA
02/2024 - 01/2022

Therapy/Procedure

60Therapeutics
03/2024 - 12/2002
8Immunotherapy
03/2024 - 12/2002
7Drug Therapy (Chemotherapy)
03/2021 - 12/2006
4Oral Administration
07/2022 - 12/2014
3Transplantation
01/2020 - 01/2019